Back to
Trexquant Investment LP
TVTX
17 quarters
Position history for
Trexquant Investment LP's holdings in Travere Therapeutics, Inc.
No. Trexquant Investment exited its TVTX (Travere Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 18,568 shares worth $443,775. Trexquant Investment first reported TVTX in Q2 2021 and held it in 13 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$292,000
Total Shares Change
-19,990
Quarter-by-Quarter History
Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.